Alibaba Health Information Technology Ltd
HKEX:241
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.62
6.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Alibaba Health Information Technology Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | HK |
Market Cap | 56.4B HKD |
Net Margin |
4%
|
Country | US |
Market Cap | 2.1T USD |
Net Margin |
8%
|
Country | ZA |
Market Cap | 831B Zac |
Net Margin |
44%
|
Country | CN |
Market Cap | 199.1B USD |
Net Margin |
9%
|
Country | CN |
Market Cap | 139B USD |
Net Margin |
29%
|
Country | CN |
Market Cap | 891.3B HKD |
Net Margin |
7%
|
Country | UY |
Market Cap | 2.1T MXN |
Net Margin |
8%
|
Country | AR |
Market Cap | 101.2B USD |
Net Margin |
8%
|
Country | NL |
Market Cap | 93B EUR |
Net Margin |
121%
|
Country | US |
Market Cap | 73.6B USD |
Net Margin |
-2%
|
Country | CN |
Market Cap | 386.4B HKD |
Net Margin |
3%
|
Alibaba Health Information Technology Ltd
Glance View
Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China. As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Alibaba Health Information Technology Ltd's most recent financial statements, the company has Net Margin of 4.3%.